MSc in Cancer Therapies, University of Strathclyde

12 Months

Check Eligibility

About this course

The MSc in Cancer Therapies is a unique programme in the UK that combines cancer biology, drug discovery, formulation and delivery with radiation biology. It focuses on anti-cancer treatment therapies, especially personalised medicine, preparing students for roles in global drug discovery and cancer treatment development. Taught at the Strathclyde Institute of Pharmacy & Biomedical Sciences, a leading department with major facilities, students will learn from researchers at the forefront of cancer research, gaining practical skills across multidisciplinary topics essential to understanding and developing cancer therapies. The course includes a major research project and offers the Margaret Boyd Memorial Award to top students, emphasizing excellence in cancer therapies.

Why this course is highly recommended

This course stands out as the only UK programme that integrates cancer biology, drug discovery, formulation, delivery, and radiation biology. It combines theoretical learning with practical research, facilitated by state-of-the-art facilities like the Cancer Research UK Drug Formulation Unit and radiobiology labs. The programme prepares graduates for diverse careers in industry, research, healthcare, and academia, supported by expert faculty involved in cutting-edge research with global collaborations. Students benefit from a multidisciplinary approach, practical skills, and industry links, making it highly relevant in today’s growing field of cancer therapies.

Specialisation

The programme is focused on cancer biology, drug discovery, formulation, delivery, and radiation biology, with an emphasis on personalised medicine and anti-cancer treatments. It offers in-depth knowledge of current and emerging therapies, radiotherapy, drug development, and clinical trial design, tailored for students seeking comprehensive expertise in cancer therapies from basic science to practical applications.

Course fees

Application fees

1st year tuition fees

29.03L

Living cost

Degree requirements

Applicants need a minimum second-class (2.2) Honours degree or equivalent in a science or health-related subject. Alternative entry standards or professional experience may also be considered, with a pathway through a Diploma course and subsequent transfer to the MSc upon satisfactory assessment. English language proficiency requires a minimum IELTS score of 6.0, with no component below 5.5.

English language test

DUOLINGO

IELTS

TOEFL

PTE

Want to learn more about the admission process, eligibility criteria, and acceptance rates for international students? Visit the University of Strathclyde admission page for complete details.

Career prospects

Graduates can pursue careers in healthcare, academia, scientific research, industry, sales, teaching, business management, technical laboratory roles, scientific writing, and public health. The course provides a solid foundation for clinical research, pharmaceutical and biotech industry roles, laboratory support, medical sales, patent work, ethics, and further PhD studies. Alumni have gone on to senior academic positions, clinical research roles, and industry-led projects, benefiting from strong industry links and a professional network.

FAQs

What are the core skills I will gain from this course?

You will develop skills in assessing, analyzing, and evaluating cancer therapies, alongside research training, drug development, radiobiology, and clinical trial understanding.

What facilities are available for students?

Students benefit from the Strathclyde Institute of Pharmacy & Biomedical Sciences, including the Cancer Research UK Formulation Unit and advanced laboratories for radiobiology and drug research.